Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.
about
Subversion of Host Innate Immunity by Uropathogenic Escherichia coliMolecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coliCrystal Structures of the Toll/Interleukin-1 Receptor (TIR) Domains from the Brucella Protein TcpB and Host Adaptor TIRAP Reveal Mechanisms of Molecular MimicryTranscriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective AntibioticsA Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors.A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.Two TIR-like domain containing proteins in a newly emerging zoonotic Staphylococcus aureus strain sequence type 398 are potential virulence factors by impacting on the host innate immune responseInnate immunity and genetic determinants of urinary tract infection susceptibility.Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)--and non-ESBL-producing uropathogenic E. coli.Activation of endogenous anti-inflammatory mediator cyclic AMP attenuates acute pyelonephritis in mice induced by uropathogenic Escherichia coli.Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli.The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917.Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.Faecal Escherichia coli isolates show potential to cause endogenous infection in patients admitted to the ICU in a tertiary care hospital.Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response.Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.A Comparative Analysis of the Mechanism of Toll-Like Receptor-Disruption by TIR-Containing Protein C from Uropathogenic Escherichia coli.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions.The Genetics of Urinary Tract Infections and the Innate Defense of the Kidney and Urinary tractUropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation.Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritisCloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of the TIR domain from the Brucella melitensis TIR-domain-containing protein TcpB.Lipopolysaccharide Domains Modulate Urovirulence.Genetics of innate immunity and UTI susceptibility.Subversion of innate immune responses by bacterial hindrance of NF-κB pathway.Bacterial TIR-containing proteins and host innate immune system evasion.Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3KBacterial interference with canonical NFκB signalling.Urinary tract infection of mice to model human disease: Practicalities, implications and limitations.The yin-yang driving urinary tract infection and how proteomics can enhance research, diagnostics, and treatment.T3SS-Independent Uptake of the Short-Trip Toxin-Related Recombinant NleC Effector of Enteropathogenic Escherichia coli Leads to NF-κB p65 Cleavage.TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target.Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.Urinary tract infection: recent insight into the evolutionary arms race between uropathogenic Escherichia coli and our immune system.Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli.tcpC as a prospective new virulence marker in blood Escherichia coli isolates from sepsis patients admitted to the intensive care unit.
P2860
Q26770272-0E89839F-1A1C-485E-84C0-73BB349AB60FQ27677266-91FED54C-C369-4355-A2CF-F74176DF39DBQ27680681-795DF2B9-D7F2-4375-942A-EFE68726CFC4Q33790123-4F261F94-78CE-44E2-AD6D-0127F160364FQ33863431-5BF31348-E81F-457D-8BC7-BD8056920CC7Q34345726-FD86A6F8-B055-488F-8B0B-D68D86290451Q34662391-FBDEE2D1-9738-4348-8B01-198CA0184B3DQ34856462-4BE99202-D885-410A-AC9D-2138D9DFC057Q34995541-6D6F7834-BCFA-4275-A6E8-2F820ACC826BQ35008536-B3C5F2F5-1D3F-48EB-833B-F6C8B5193FADQ35025542-08661C02-88C2-49E6-8F3F-714F82F81E59Q35827663-762DC40C-DC1C-4EFF-B409-E0131C72D037Q35852635-6D3F52BE-F3E9-4FD4-A0E2-D4E9A43D3834Q35909495-35EABC03-F8DE-4728-8C3E-589199ACD330Q36127190-26CFFCBD-0674-4ED9-88B9-176952AF1EE9Q36163174-9149C786-1FD4-4FF5-94D6-FA9BEC68067CQ36735431-4A921134-859A-4C54-9A4E-29842B9E9FFAQ36910650-79CB2FB6-C580-4C87-947E-4FEE88B0ADFEQ36951570-F0B4F1FC-EEF1-4787-A5B3-093288ED2017Q36989053-F2A69B63-3EF1-4D4E-A7AF-EE7DEF85BA75Q37032677-2C1670E8-4B5C-4403-B5A3-239109F5A919Q37042305-E725343F-973F-44DB-809A-FD4AB623C114Q37066063-691B9AB2-0A8F-4B8F-BFE8-70D6DE13F838Q37201208-B1A03066-32E3-4821-9EDD-56F04E83D791Q37220651-72F6C60E-C0DE-4DB0-B806-1A75E76EF4D4Q37345901-A1E37594-27CE-4610-9E17-8AE17B3460B1Q37900471-EB34EEAB-3E06-4EDF-B3D2-A192A61344CFQ37951705-34A6D57D-A8E9-4331-A7E5-C938A4255D8DQ38024677-BAC82CDF-8699-4C77-8D3F-7135F79DCF64Q38034857-DF0F9F49-38D0-47ED-9688-37A492D64A7CQ38123136-C27E9B5E-072C-4E72-9EF3-48F7538CCAAAQ38501348-D710697E-B51A-45B6-A5AB-C04BE952F180Q38563209-344AF762-D74B-470A-BBC9-D4741F56BC4FQ38689964-D71253E7-9B56-4499-8CD5-F2009ECF9B49Q38830698-02E3B916-8366-4281-9325-38F46E0DD5F0Q40163535-686990A3-96DF-4181-80DA-6F1645BBCA82Q40279563-32F4043F-2183-4584-B94D-58740E0752ADQ41022801-439DBF8D-00D6-4685-828C-0BD1F4CABA1BQ41213859-EC3E9A3F-8750-488A-9A7D-A0CA74BF96E8Q41624145-E3BB58F0-0770-4981-996B-4F0AE8FA8890
P2860
Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of TIR domain signa ...... on Escherichia coli virulence.
@ast
Inhibition of TIR domain signa ...... on Escherichia coli virulence.
@en
type
label
Inhibition of TIR domain signa ...... on Escherichia coli virulence.
@ast
Inhibition of TIR domain signa ...... on Escherichia coli virulence.
@en
prefLabel
Inhibition of TIR domain signa ...... on Escherichia coli virulence.
@ast
Inhibition of TIR domain signa ...... on Escherichia coli virulence.
@en
P2093
P2860
P1433
P1476
Inhibition of TIR domain signa ...... on Escherichia coli virulence.
@en
P2093
Catharina Svanborg
Christine Cirl
Hans Fischer
Jingyao Zhang
Josephine Lum
Manisha Yadav
Nataliya Lutay
Thomas Miethke
P2860
P304
P356
10.1371/JOURNAL.PPAT.1001120
P577
2010-09-23T00:00:00Z